Calendar

pharmadog

Week of Oct 27, 2025

Oct 29, 2025approval291d agoKETALAR (KETAMINE HYDROCHLORIDE) — FDA approvalPar Pharmaceutical Inc

Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 29, 2025approval291d agoNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (HYDROCORTISONE) — FDA approvalET-800

Sponsor: AMNEAL. Form: SOLUTION/DROPS. Route: OTIC

full page →ET-800 →fda approvals ↗

Oct 29, 2025approval291d agoJUBBONTI (DENOSUMAB-BBDZ) — FDA approvalJUBBONTI

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →JUBBONTI →fda approvals ↗

Oct 29, 2025approval291d agoHIBICLENS (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

Sponsor: MOLNLYCKE HLTH. Form: SOLUTION. Route: TOPICAL

full page →fda approvals ↗

Oct 29, 2025approval291d agoDENOSUMAB-DSSB — FDA approvaldenosumab biosimilar

Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →denosumab biosimilar →fda approvals ↗

Oct 29, 2025approval291d agoCONEXXENCE (DENOSUMAB-BNHT) — FDA approvalCONEXXENCE

Sponsor: FRESENIUS KABI USA LLC. Form: INJECTION

full page →CONEXXENCE →fda approvals ↗

Oct 29, 2025approval291d agoOSENVELT (DENOSUMAB-BMWO) — FDA approvalOSENVELT

Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION

full page →OSENVELT →fda approvals ↗

Oct 29, 2025approval291d agoOSVYRTI (denosumab-desu) — FDA approvalOSVYRTI

Sponsor: ACCORD BIOPHARMA INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →OSVYRTI →fda approvals ↗

Oct 29, 2025approval291d agoPOSACONAZOLE — FDA approvalPOSACONAZOLE

Sponsor: MSN. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →POSACONAZOLE →fda approvals ↗

Oct 29, 2025approval291d agoPIFELTRO (DORAVIRINE) — FDA approvaldoravirine

Sponsor: MSD MERCK CO. Form: TABLET. Route: ORAL

full page →doravirine →fda approvals ↗

Oct 29, 2025approval291d agoDELSTRIGO (DORAVIRINE) — FDA approval(doravirine + lamivudine + tenofovir disoproxil fumarate)

Sponsor: MSD MERCK CO. Form: TABLET. Route: ORAL

full page →(doravirine + lamivudine + tenofovir disoproxil fumarate) →fda approvals ↗

Oct 29, 2025approval291d agoAUKELSO (DENOSUMAB-KYQQ) — FDA approvalAUKELSO

Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION

full page →AUKELSO →fda approvals ↗

Oct 29, 2025approval291d agoENOBY (DENOSUMAB-QBDE) — FDA approvalENOBY

Sponsor: HIKMA PHARMACEUTICALS USA INC. Form: SOLUTION. Route: INJECTION

full page →ENOBY →fda approvals ↗

Oct 29, 2025approval291d agoBILPREVDA (DENOSUMAB-NXXP) — FDA approvalBILPREVDA

Sponsor: SHANGHAI HENLIUS BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →BILPREVDA →fda approvals ↗

Oct 29, 2025approval291d agoVARENICLINE TARTRATE — FDA approvalVARENICLINE TARTRATE

Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

full page →VARENICLINE TARTRATE →fda approvals ↗

Oct 29, 2025approval291d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

full page →cemiplimab →fda approvals ↗

Oct 29, 2025approval291d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

Sponsor: GRANULES. Form: TABLET. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗

Oct 30, 2025approval290d agoTYRUKO (NATALIZUMAB-SZTN) — FDA approvalnatalizumab biosimilar

Sponsor: SANDOZ INC. Form: INJECTABLE. Route: INJECTION

full page →natalizumab biosimilar →fda approvals ↗

Oct 30, 2025approval290d agoVIMIZIM (ELOSULFASE ALFA) — FDA approvalBIOMARIN PHARMACEUTICAL INC

Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 30, 2025approval290d agoHALDOL (HALOPERIDOL DECANOATE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Oct 30, 2025approval290d agoAXITINIB — FDA approvalaxitinib SR

Sponsor: APOTEX. Form: TABLET. Route: ORAL

full page →axitinib SR →fda approvals ↗

Oct 30, 2025approval290d agoEVEROLIMUS — FDA approvalPostsurgical Therapeutics Inc

Sponsor: NOVUGEN. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 31, 2025approval289d agoPENICILLIN V POTASSIUM — FDA approvalNorthstar Rx LLC

Sponsor: CHARTWELL RX. Form: FOR SOLUTION. Route: ORAL

full page →fda approvals ↗

Oct 31, 2025approval289d agoVOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approvalamoxicillin + clarithromycin + vonoprazan

Sponsor: PHATHOM. Form: CAPSULE, TABLET, TABLET. Route: ORAL

full page →amoxicillin + clarithromycin + vonoprazan →fda approvals ↗

Oct 31, 2025approval289d agoVOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approvalamoxicillin + vonoprazan fumarate

Sponsor: PHATHOM. Form: CAPSULE, TABLET. Route: ORAL

full page →amoxicillin + vonoprazan fumarate →fda approvals ↗

Oct 31, 2025approval289d agoPENICILLIN V POTASSIUM — FDA approvalNorthstar Rx LLC

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 31, 2025approval289d agoPENICILLIN V POTASSIUM — FDA approvalNorthstar Rx LLC

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 1, 2025grant288d agoUNIVERSITY OF COLORADO DENVER — Enhancement of Effector CD8 Cell Motility through Mitochondrial MetabolismUniversity of Colorado Denver

AI grant. $38,093. PI: Maureen E Hoen Rauhut

full page →nih reporter ↗

Nov 1, 2025grant288d agoYALE UNIVERSITY — Impact of Natural Infection on the Baseline Immune States in Humans

AI grant. $34,558. PI: Yona Lei

full page →nih reporter ↗

Nov 1, 2025grant288d agoEMORY UNIVERSITY — Capsid assembly mechanisms of Kaposi Sarcoma associated herpesvirusEmory University

AI grant. $78,052. PI: Shea Lowery

full page →nih reporter ↗

Nov 1, 2025grant288d agoPRINCETON UNIVERSITY — Molecular and Cellular Determinants of Tolerance to Second Generation Antipsy...

MH grant. $33,538. PI: Elinor Lewis

full page →nih reporter ↗

Nov 1, 2025grant288d agoBROWN UNIVERSITY — TAC1 Tango: Evolutionary rewiring of a transcriptional circuit for azole drug...

AI grant. $75,520. PI: Nicholas Cauldron

full page →nih reporter ↗

Nov 1, 2025grant288d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

AI grant. $19,000. PI: JASON B HARRIS

full page →nih reporter ↗

Nov 1, 2025grant288d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Oral Microbiome Dysregulation as a Contributor to Depressive Symptoms and Alt...University of California Los Angeles

MH grant. $42,489. PI: Naomi Gancz

full page →nih reporter ↗

Nov 1, 2025grant288d agoJOHNS HOPKINS UNIVERSITY — Microbiota mechanisms promoting Clostridioides difficile colon persistenceJohns Hopkins University

AI grant. $49,538. PI: Hadley Beauregard

full page →nih reporter ↗

Nov 1, 2025grant288d agoHARVARD MEDICAL SCHOOL — Molecular Transport of IFT Complexes in Leishmania

AI grant. $44,020. PI: Tierra Buck

full page →nih reporter ↗

Nov 1, 2025grant288d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — How does myelin plasticity influence neural circuit dynamics required for lon...University of California San Francisco

MH grant. $75,052. PI: Manasi Iyer

full page →nih reporter ↗

Nov 1, 2025grant288d agoMASSACHUSETTS GENERAL HOSPITAL — Antibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital

AI grant. $99,429. PI: JASON B HARRIS

full page →nih reporter ↗

Nov 1, 2025grant288d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Longitudinal Impact of Health and Lifestyle Behaviors on Cognition in Individ...

HD grant. $75,600. PI: Michelle H Chen

full page →nih reporter ↗

Nov 1, 2025grant288d agoUNIVERSITY OF SOUTHERN CALIFORNIA — Syphilis Immunology and Biology to Improve Clinical Management and Vaccine De...University of Southern California

AI grant. $238,136. PI: Jeffrey David Klausner

full page →nih reporter ↗

Nov 1, 2025grant288d agoUNIVERSITY OF TEXAS MED BR GALVESTON — Initiate Research, Opportunities, and Networks for Early Career Investigators...

DK grant. $103,081. PI: Brittany L. Smalls

full page →nih reporter ↗

Nov 1, 2025grant288d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Triggers of food allergen absorption and anaphylaxisNorthwestern University

AI grant. $53,461. PI: Danielle Rose Jacobsen

full page →nih reporter ↗

Nov 1, 2025grant288d agoEMORY UNIVERSITY — Molecular determinants of Streptococcus pyogenes adhesion to pyroptotic kerat...Emory University

AI grant. $49,538. PI: Jacob D Sherman

full page →nih reporter ↗

Nov 1, 2025grant288d agoVANDERBILT UNIVERSITY MEDICAL CENTER — All of Us Research Program Data and Research Center

OD grant. $2,500,000. PI: Melissa Basford

full page →nih reporter ↗

Nov 1, 2025grant288d agoUNIVERSITY OF IOWA — Developing real-time personalized TMS to target residual corticospinal connec...University of Iowa

NS grant. $245,687. PI: Sara J Hussain

full page →nih reporter ↗

Nov 1, 2025grant288d agoOHIO STATE UNIVERSITY — Epigenetic Regulation of KSHV

AI grant. $85,360. PI: Kurtis Matthew Host

full page →nih reporter ↗

Nov 1, 2025grant288d agoJOHNS HOPKINS UNIVERSITY — Chemosensory Mechanisms Driving Malaria TransmissionJohns Hopkins University

AI grant. $103,760. PI: Conor James McMeniman

full page →nih reporter ↗

Nov 1, 2025grant288d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — 2025 Rachmiel Levine-Arthur Riggs Diabetes Research SymposiumCity of Hope

DK grant. $20,000. PI: FOUAD R KANDEEL

full page →nih reporter ↗

Nov 1, 2025grant288d agoUNIVERSITY OF CALIFORNIA BERKELEY — Elucidating the mechanism and correlates of protection elicited by CDN adjuva...

AI grant. $48,395. PI: Isabel Lamb-Echegaray

full page →nih reporter ↗

Nov 1, 2025grant288d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Strategies and Consequences of Polymicrobial Nasal Colonization

AI grant. $75,520. PI: Shyra Wilde

full page →nih reporter ↗

← prev

page 1 of 90

Week of Oct 27, 2025